Disease-modifying treatment does not influence severity and recovery of the first relapse after treatment onset in RRMS: insights from four large-scale clinical trials
Year: 2026
Type: article
Source: Multiple Sclerosis Journal
Institutions: University of Calgary, Rijnstate Hospital, Amsterdam UMC, Amsterdam UMC Location Vrije Universiteit Amsterdam, Universitair Ziekenhuis Brussel, National MS Center Melsbroek, Haukeland University Hospital, University of Bergen, Hospital de Sant Joan Despí Moisès Broggi, Hospital Universitari Arnau de Vilanova, Université de Montréal, Emory University, University of Alabama at Birmingham
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7236798964
